SAGE

Artal Group’s Sage Therapeutics SAGE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-500,000	Closed	-$23.5M	–	113
2023 Q2	$23.5M	Sell	500,000 -250,000	-33%	-$11.8M	0.73%	19
2023 Q1	$31.5M	Hold	750,000	–	–	1.87%	16
2022 Q4	$28.6M	Hold	750,000	–	–	1.6%	19
2022 Q3	$29.4M	Buy	750,000 +300,000	+67%	+$11.7M	1.25%	23
2022 Q2	$14.5M	Sell	450,000 -300,000	-40%	-$9.69M	0.78%	29
2022 Q1	$24.8M	Sell	750,000 -250,000	-25%	-$8.28M	1.04%	22
2021 Q4	$42.5M	Hold	1,000,000	–	–	1.15%	22
2021 Q3	$44.3M	Hold	1,000,000	–	–	0.99%	22
2021 Q2	$56.8M	Buy	1,000,000 +350,000	+54%	+$19.9M	1.15%	17
2021 Q1	$48.7M	Buy	650,000 +250,000	+63%	+$18.7M	0.86%	20
2020 Q4	$34.6M	Buy	400,000 +177,700	+80%	+$15.4M	0.74%	33
2020 Q3	$13.6M	Sell	222,300 -11,700	-5%	-$715K	0.33%	55
2020 Q2	$9.73M	Sell	234,000 -116,000	-33%	-$4.82M	0.27%	57
2020 Q1	$10.1M	Buy	350,000 +200,000	+133%	+$5.74M	0.42%	40
2019 Q4	$10.8M	Hold	150,000	–	–	0.42%	40
2019 Q3	$21M	Hold	150,000	–	–	0.84%	18
2019 Q2	$27.5M	Buy	150,000 +25,000	+20%	+$4.58M	1.11%	19
2019 Q1	$19.9M	Buy	125,000 +25,000	+25%	+$3.98M	0.81%	23
2018 Q4	$9.58M	Hold	100,000	–	–	0.35%	31
2018 Q3	$14.1M	Hold	100,000	–	–	0.37%	25
2018 Q2	$15.7M	Hold	100,000	–	–	0.33%	19
2018 Q1	$16.1M	Buy	100,000 +25,000	+33%	+$4.03M	0.2%	19
2017 Q4	$12.4M	Sell	75,000 -75,000	-50%	-$12.4M	0.19%	21
2017 Q3	$9.35M	Buy	150,000 +60,000	+67%	+$3.74M	0.16%	24
2017 Q2	$7.17M	Sell	90,000 -85,000	-49%	-$6.77M	0.13%	25
2017 Q1	$12.4M	Buy	175,000 +25,000	+17%	+$1.78M	0.28%	16
2016 Q4	$7.66M	Sell	150,000 -50,000	-25%	-$2.55M	0.17%	22
2016 Q3	$9.21M	Buy	+200,000	New	+$9.21M	0.18%	20
2016 Q2	–	Hold	0	–	–	–	63